|
DCBLD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.161800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.486400E-02 |
| Normal-vs-Stage2 |
8.664400E-01 |
| Normal-vs-Stage3 |
8.058000E-01 |
| Normal-vs-Stage4 |
6.076600E-01 |
| Stage1-vs-Stage2 |
1.943200E-01 |
| Stage1-vs-Stage3 |
2.527000E-01 |
| Stage1-vs-Stage4 |
1.062830E-01 |
| Stage2-vs-Stage3 |
9.356200E-01 |
| Stage2-vs-Stage4 |
5.645600E-01 |
| Stage3-vs-Stage4 |
5.540600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.863000E-01 |
| Normal-vs-AfricanAmerican |
3.377600E-01 |
| Normal-vs-Asian |
6.771800E-01 |
| Caucasian-vs-AfricanAmerican |
4.931200E-01 |
| Caucasian-vs-Asian |
9.906600E-01 |
| AfricanAmerican-vs-Asian |
6.137600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.643600E-01 |
| Normal-vs-Female |
3.015600E-01 |
| Male-vs-Female |
6.697200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.087700E-02 |
| Normal-vs-Age(41-60Yrs) |
7.163000E-01 |
| Normal-vs-Age(61-80Yrs) |
7.504200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.940200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.867800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.430200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.390000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.511400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.233000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.561600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.019800E-01 |
| Classical-VS-Follicular |
6.342400E-01 |
| Classical-VS-Other |
8.957200E-01 |
| Classical-VS-Normal |
1.960160E-01 |
| Tall-VS-Follicular |
4.866400E-01 |
| Tall-VS-Other |
8.710600E-01 |
| Tall-VS-Normal |
9.386000E-01 |
| Follicular-VS-Other |
7.512200E-01 |
| Follicular-VS-Normal |
1.385800E-01 |
| Other-VS-Normal |
8.381200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.454400E-01 |
| Normal-vs-N1 |
9.198600E-01 |
| N0-vs-N1 |
6.227000E-01 |
|
|
